Acquisition - October 11, 2023
Getinge acquires Healthmark Industries
Getinge has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a provider of instrument care and infection control consumables, for approximately 320 million USD. This strategic step enhances Getinge’s presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark, it states. “We are excited and honored to […]
Acquisition - September 27, 2023
Scantox acquires Q&Q Labs
With this acquisition Scantox has nearly 200 employees across four sites. “Scantox embarked on an ambitious growth journey when we acquired the first two international companies last year, and we are thrilled to now expand our Group further with the acquisition of Q&Q. We welcome a company known for their solid expertise within the field […]
Acquisition - September 5, 2023
Dynamic Code acquires FindOut Diagnostic
Dynamic Code has acquired the bankrupt FindOut Diagnostic, a medical technology company that develops and manufactures self-tests. The company launched self-tests for CRP (rapid lowering) and HbA1c (long-term blood sugar) at the beginning of the year. The company’s products are well in line with Dynamic Code’s strategy to expand the product portfolio, the company states. […]
Acquisition - August 28, 2023
LEO Pharma acquires Timber Pharmaceuticals
LEO Pharma has signed an agreement to acquire US-listed Timber Pharmaceuticals. Upon closing, this transaction will add an attractive late-stage asset to LEO Pharma’s pipeline in medical dermatology, the company states. “Signing an agreement to acquire Timber Pharmaceuticals and TMB-001, which is still subject to certain closing conditions, is an additional step in delivering on […]
Acquisition - August 10, 2023
Novo Nordisk to acquire Inversago Pharma
Novo Nordisk has agreed to acquire Inversago Pharma for up to 1.075 billion USD in cash if certain development and commercial milestones are achieved. “The acquisition of Inversago Pharma will further strengthen our clinical development pipeline in obesity and related disorders,” says Martin Holst Lange, executive vice president for Development at Novo Nordisk. “This promising […]
Acquisition - August 8, 2023
ADDvise acquires Diabetic Supplies
ADDvise Group has entered into a share purchase agreement with the owners of Diabetic Supplies Inc regarding the acquisition of all shares of Diabetic Supplies. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue for the last twelve months per June 30, 2023, amounted to USD […]